Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 7Brain Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Inflammatory Breast Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma 2Vaginal Neoplasms 1

Interventions

Gemcitabine 2liposomal doxorubicin 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Pafolacianine 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pelvic Neoplasms × Surgical Procedures, Operative × Clear all
NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic

Phase 3 Recruiting
20 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡